CGON vs KOD: stock comparison and AI forecast
Cg Oncology, Inc. (CGON) and Kodiak Sciences Inc. (KOD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CGON Cg Oncology, Inc.
- Price
- $61.96 -8.5% · 6M
- Market Cap
- $5.49B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
KOD Kodiak Sciences Inc.
- Price
- $99.18 +128.1% · 6M
- Market Cap
- $6.23B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- KOD is 1.1 times larger than CGON by market capitalization ($6.23B against $5.49B).
- Over the last six months KOD returned +128.1% and CGON -8.5%.
- KOD carries 3.20 times debt per unit of equity, against 0.05 times for CGON.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CGON | KOD |
|---|---|---|
| Market Cap | $5.49B | $6.23B |
| P/B Ratio | 5.34x | 102.03x |
| EPS | $-2.44 | $-3.25 |
| Book Value/Share | $11.61 | $0.97 |
| Revenue/Share | $0.07 | – |
| FCF/Share | $-2.02 | $-2.54 |
Profitability & Margins
| Metric | CGON | KOD |
|---|---|---|
| ROE | -21.8% | -396.1% |
| ROA | -20.7% | -94.2% |
| ROIC | -24.3% | -120.8% |
| Operating Margin | -4056.2% | – |
| Net Margin | -3602.7% | – |
| EBT Margin | -4056.2% | – |
| Tax Rate | 0.1% | – |
Financial Health
| Metric | CGON | KOD |
|---|---|---|
| Current Ratio | 22.22x | 2.49x |
| Quick Ratio | 22.20x | – |
| D/E Ratio | 0.05x | 3.20x |
| Financial Leverage | 1.05x | 4.20x |
| Interest Coverage | -1838.3x | -8426.3x |
| Working Capital | $1.00B | $79M |
Cash Flow
| Metric | CGON | KOD |
|---|---|---|
| Operating Cash Flow | -$178M | -$158M |
| Free Cash Flow | -$179M | -$160M |
| Capital Spending | -$880K | -$1M |
| FCF/Sales | -2879.6% | – |
| CapEx/Sales | 14.1% | – |
Operational Efficiency
| Metric | CGON | KOD |
|---|---|---|
| Asset Turnover | 0.01x | – |
| Receivables Turnover | 14.9x | – |
| Fixed Assets Turnover | 0.4x | – |
| Days Sales Outstanding | 24 days | – |
Income Statement
| Metric | CGON | KOD |
|---|---|---|
| Total Revenue | $6M | – |
| Operating Income | -$253M | -$246M |
| Net Income | -$224M | -$242M |
| R&D Expense | $156M | $201M |
Dividend & Shareholder Information
| Metric | CGON | KOD |
|---|---|---|
| Shares Outstanding | 89M | 63M |
CGON vs KOD: stock comparison and AI forecast
Which is bigger, CGON or KOD?
KOD is 1.1 times larger than CGON by market capitalization ($6.23B against $5.49B).
Which stock performed better over the last six months, CGON or KOD?
Over the last six months KOD returned +128.1% and CGON -8.5%.
Which one does Intratio's AI model rank higher, CGON or KOD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.